Acellular Scaffolds as Innovative Biomaterial Platforms for the Management of Diabetic Wounds

10Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Diabetic wound (DW) is one of the leading complications of patients having a long history of uncontrolled diabetes. Moreover, it also imposes an economic burden on people suffering from wounds to manage the treatment. The major impending factors in the treatment of DW are infection, prolonged inflammation and decreased oxygen levels. Since these non-healing wounds are associated with an extended recovery period, the existing therapies provide treatment for a limited period only. The areas covered in this review are general sequential events of wound healing along with DW's pathophysiology, the origin of DW and success, as well as limitations of existing therapies. This systematic review's significant aspect is to highlight the fabrication, characterization and applications of various acellular scaffolds used to heal DW. In addition to that, cellular scaffolds are also described to a limited extent.

Cite

CITATION STYLE

APA

Tallapaneni, V., Kalaivani, C., Pamu, D., Mude, L., Singh, S. K., & Karri, V. V. S. R. (2021, October 1). Acellular Scaffolds as Innovative Biomaterial Platforms for the Management of Diabetic Wounds. Tissue Engineering and Regenerative Medicine. Korean Tissue Engineering and Regenerative Medicine Society. https://doi.org/10.1007/s13770-021-00344-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free